Media pushes success of GSK malaria vaccine while ignoring deadly side effects

Mainstream media is excited over GlaxoSmithKline’s latest offering, a malaria trial vaccine that the company claims can cut the risk of clinical and severe malaria in children by 56% and 47%, respectively. But what GSK and the media do not report are the vaccine’s deadly side effects.

Bill & Melinda Gates Foundation suggest that children who receive three doses will have additional protection against malaria when used in conjunction with other disease control methods. But the findings also show that vaccinated children are at a high risk of serious injury or death as well.

Learn more

ANNONS

Hälsofrihet NHFsweden

Kommentera

%d bloggare gillar detta: